Search Within

Aaron David Goldberg

Formats
  1. Meeting Abstract (69)
  2. Journal Article (30)
  3. Research Letter (6)
  4. Correspondence (3)
  5. Editorial (3)
  6. Review (2)
  7. Book Section (1)
Groups
  1. Adult Leukemia (114)
  2. Center for Hematologic Malignancies (114)
  3. Department of Medicine (114)
  4. Hematologic Malignancies, Division of (114)
  5. Weinberg Fellows (114)
  6. Hematology-Oncology Fellows (52)

More Groups

People
  1. Martin Tallman (47)
  2. Eytan Stein (41)
  3. Christopher Famulare (37)
  4. Ross Levine (21)
  5. Andriy Derkach (20)
  6. Jan Bewersdorf (19)

More People

Years
  1. 2025 (2)
  2. 2024 (19)
  3. 2023 (20)
  4. 2022 (15)
  5. 2021 (15)
  6. 2020 (15)

More Years

Publications
  1. Blood (63)
  2. Leukemia and Lymphoma (8)
  3. American Journal of Hematology (6)
  4. Blood Advances (5)
  5. Journal of Clinical Oncology (5)
  6. Haematologica (4)

More Publications

Publishers
  1. American Society of Hematology (68)
  2. Taylor & Francis Group (8)
  3. American Society of Clinical Oncology (6)
  4. John Wiley & Sons, Inc. (6)
  5. Ferrata Storti Foundation (4)
  6. Nature Publishing Group (4)

More Publishers

Results (114)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Racial disparities in patients with TP53 mutated acute myeloid leukemia
    Meeting Abstract

    Badar, T.; Litzow, M. R.; Shallis, R.; Stahl, M.; Bewersdorf, J. P.; Saliba, A. N.; de Camargo Correia, G. S.; Patel, A. A.; Abaza, Y.; Murthy, G. S. G.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Long-term results of a phase 2 trial of crenolanib combined with 7+3 chemotherapy in adults with newly diagnosed FLT3 mutant AML
    Meeting Abstract

    Wang, E. S.; Goldberg, A. D.; Walter, R. B.; Collins, R.; Stone, R. M.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • A phase 1b study of atezolizumab in combination with guadecitabine for the treatment of acute myeloid leukemia
    Journal Article

    Prebet, T.; Goldberg, A. D.; Jurcic, J. G.; Khaled, S.; Dail, M.; Feng, Y.; Green, C.; Li, C.; Ma, C.; Medeiros, B. C.; more...
    Leukemia and Lymphoma (2022)

    Fulltext@MSK | Save
  • Efficacy of FLT3 and IDH1/2 inhibitors in patients with acute myeloid leukemia previously treated with venetoclax
    Journal Article

    Bewersdorf, J. P.; Shallis, R. M.; Derkach, A.; Goldberg, A. D.; Stein, A.; Stein, E. M.; Marcucci, G.; Zeidan, A. M.; Shimony, S.; DeAngelo, D. J.; more...
    Leukemia Research (2022)

    Fulltext@MSK | Save
  • Outcomes of TP53-mutated AML with evolving frontline therapies: Impact of allogeneic stem cell transplantation on survival
    Correspondence

    Badar, T.; Atallah, E.; Shallis, R. M.; Goldberg, A. D.; Patel, A.; Abaza, Y.; Bewersdorf, J. P.; Saliba, A. N.; Correia, G. S. D. C.; Murthy, G.; more...
    American Journal of Hematology (2022)

    Fulltext@MSK | Save
  • Multicenter evaluation of efficacy and toxicity of venetoclax-based combinations in patients with accelerated and blast phase myeloproliferative neoplasms
    Research Letter

    King, A. C.; Weis, T. M.; Derkach, A.; Ball, S.; Pandey, M.; Mauro, M. J.; Goldberg, A. D.; Stahl, M.; Famulare, C.; Tallman, M. S.; more...
    American Journal of Hematology (2022)

    Fulltext@MSK | Save
  • Real-world management of patients with newly diagnosed acute myeloid leukemia treated with venetoclax-based regimens: Results from the AML Real World Evidence (ARC) Initiative
    Meeting Abstract

    Vachhani, P.; Wolach, O.; Garcia, J. S.; Zeidner, J. F.; Talati, C.; Pollyea, D. A.; Lai, C.; Moshe, Y.; Abedin, S.; Lavie, D.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Safety and efficacy of CPX-351 in younger patients < 60 years old with secondary acute myeloid leukemia: An updated analysis
    Meeting Abstract

    Przespolewski, A.; Goldberg, A. D.; Talati, C.; Fazal, S.; Vachhani, P.; Sanikommu, S. R. R.; Thota, S.; Waksal, J.; Ball, B.; Famulare, C.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Risks for hospitalization and death among patients with blood disorders from the ASH RC COVID-19 Registry for Hematology
    Meeting Abstract

    Hicks, L. K.; Redd, R. A.; Anderson, K. C.; Desai, P.; Dolan, B.; Goldberg, A. D.; Narendra, V.; Neuberg, D. S.; Radhakrishnan, V.; Sehn, L. H.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Phase I and expansion study of eprenetapopt (APR-246) in combination with venetoclax (VEN) and azacitidine (AZA) in TP53-mutant acute myeloid leukemia (AML)
    Meeting Abstract

    Garcia-Manero, G.; Goldberg, A. D.; Winer, E. S.; Altman, J. K.; Fathi, A. T.; Odenike, O.; Roboz, G. J.; Gallacher, P.; Wennborg, A.; Hickman, D. K.; more...
    Blood (2021)

    Fulltext@MSK | Save